相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: Challenges and implications
Louis P. Garrison et al.
DRUG METABOLISM REVIEWS (2008)
Insurers and 'Targeted Biologics' for cancer: A conversation with Lee N. Newcomer
Barbara J. Culliton et al.
HEALTH AFFAIRS (2008)
Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice
Kathryn A. Phillips
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The meaning of translational research and why it matters
Steven H. Woolf
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Is personalized medicine finally arriving?
Malorye Allison
NATURE BIOTECHNOLOGY (2008)
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?
Muin J. Khoury et al.
GENETICS IN MEDICINE (2007)
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
Louis R. Garrison et al.
CANCER (2007)
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer
Nicola Lucio Liberato et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Concordance between central and local laboratory HER2 testing from a community-based clinical study
Josina C. Reddy et al.
CLINICAL BREAST CANCER (2006)
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
LG Dressler et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Comparative effectiveness: Asking the right questions, choosing the right method
SM Teutsch et al.
HEALTH AFFAIRS (2005)
HER-2 testing and trastuzurnab therapy for metastatic breast cancer: A cost-effectiveness analysis
EB Elkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of breast cancer patients
A Stark et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2004)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
Real-world performance of HER2 testing - National surgical adjuvant breast and bowel project experience
S Paik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
PC Roche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
分享论文
